| Literature DB >> 33630825 |
Melanie J Firestone, Alexandra J Lorentz, Xiong Wang, Kathryn Como-Sabetti, Sara Vetter, Kirk Smith, Stacy Holzbauer, Stephanie Meyer, Kristin Ehresmann, Richard Danila, Ruth Lynfield.
Abstract
On January 9, 2021, the Minnesota Department of Health (MDH) announced the identification of the SARS-CoV-2 variant of concern (VOC) B.1.1.7, also referred to as 20I/501Y.V1 and VOC 202012/01, in specimens from five persons; on January 25, MDH announced the identification of this variant in specimens from three additional persons. The B.1.1.7 variant, which is reported to be more transmissible than certain other SARS-CoV-2 lineages*,† (1), was first reported in the United Kingdom in December 2020 (1). As of February 14, 2021, a total of 1,173 COVID-19 cases of the B.1.1.7 variant had been identified in 39 U.S. states and the District of Columbia (2). Modeling data suggest that B.1.1.7 could become the predominant variant in the United States in March 2021 (3).Entities:
Mesh:
Year: 2021 PMID: 33630825 DOI: 10.15585/mmwr.mm7008e1
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 17.586